Cutaneous toxicity after intradermal vaccination with Mycobacterium vaccae against lung cancer and malignant mesothelioma [17]

British Journal of Dermatology

Volumn 144, Issue 3, 2001, Pages 648-649

  Pandha, H S ^a,b   Mortimer, P ^a   Souberbeille, B ^a   McCoubrie, P ^a   O'Brien, M E R ^a  

^a ROYAL MARSDEN HOSPITAL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MYCOBACTERIUM VACCINE; SRL 172; UNCLASSIFIED DRUG;

ADULT; AGED; CANCER IMMUNOTHERAPY; CASE REPORT; DRUG SAFETY; FEMALE; HUMAN; LETTER; LUNG SMALL CELL CANCER; MALE; MALIGNANT MESOTHELIOMA; MYCOBACTERIUM VACCAE; PRIORITY JOURNAL; SKIN TOXICITY;

AGED; CANCER VACCINES; DRUG ERUPTIONS; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MESOTHELIOMA; MIDDLE AGED; MYCOBACTERIUM;

EID: 0035083654     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.2001.04117.x     Document Type: Letter

References (8)

1. Treatment for melanoma of the lower extremity with intralesional injection of bacille Calmette-Guérin and hyperthermic perfusion
2. Bacillus Calmette-Guérin immunotherapy for bladder cancer
3. Therapeutic vaccines
4. Diagnosis of cancer-associated vascular disorders
5. Cutaneous paraneoplastic syndromes associated with lung cancer
6. Leukocytoclastic vasculitis and long-term remission in a patient with secondary AML and post-remission treatment with low-dose interleukin-2
7. Dermatologic changes associated with interleukin 2 administration
8. Delayed adverse skin reactions associated with mitomycim-C administration